1887

Abstract

The human T cell leukaemia virus type II (HTLV-II), whose pathogenicity is as yet unclear, was recently found to be associated with intravenous drug abuse in North America and Europe. HTLV-II was isolated from two Italian drug abusers belonging to the same cohort and coinfected with human immunodeficiency virus type 1. Two new isolates, HTLV-II Gu and Va, were established in a culture of BJAB cells, a continuous B cell line (Epstein–Barr virus-negative), and characterized by nucleotide sequence analysis of the long terminal repeat (LTR) and portions of the and X regions. These sequences were compared to those of the HTLV-II Mo isolate reported in the literature. No major variations were observed in important regulatory elements of LTR nor in the stem-bulge-loop configuration known to be essential for binding of rex protein. The results obtained from the sequence of the 1988 nucleotides examined indicated a 1.6% variability between the Gu and Va isolates and about 6% with respect to Mo. Notable differences were found in the structure of putative open reading frames of the X region when compared to those reported for the Mo isolate. Restriction analysis of proviral DNA of two isolates and comparison with the physical map of the Mo isolate confirmed the existence of genetic heterogeneity in the HTLV-II group and demonstrated that the new isolates Gu and Va belong to the HTLV-IIb subtype. The results of this study show that the new isolates have distinct features with respect to the Mo isolate though all important regulatory elements of the LTR appear to be well conserved.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-3-437
1993-03-01
2024-10-08
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/3/JV0740030437.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-3-437&mimeType=html&fmt=ahah

References

  1. Biggar R. I., Maloney E., Neel T. V., Blattner W. A. 1992; HTLV-II is a New World virus. AIDS Research and Human Retroviruses 8:931
    [Google Scholar]
  2. Black A. C., Chen I. S. Y., Arrigo S., Ruland C. T., Alloggiamento T., Chin E., Rosenblatt J. D. 1991; Regulation of HTLV-II gene expression by Rex involves positive and negative cis-acting elements in the 5′ long terminal repeat. Virology 181:433–444
    [Google Scholar]
  3. Cann A. J., Chen I. S. Y. 1990 Human T-cell leukemia virus type I and II. In Virology. , 2nd edn. pp. 1501–1528 Edited by Fields B. N., Knipe D. M. New York: Raven Press;
    [Google Scholar]
  4. Ciminale V., Pavlakis G. N., Derse D., Cunningham C. P., Felber B. K. 1992; Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNA and proteins produced by HTLV type I. Journal of Virology 66:1737–1745
    [Google Scholar]
  5. Ehrlich G. D., Glaser S. B., LaVigne K., Quan D., Mildvan D., Sninsky J. J., Kwok S., Papsidero L., Poiesz B. J. 1989; Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals : type-specific identification of HTLV by polymerase chain reaction. Blood 74:1658–1664
    [Google Scholar]
  6. Gelmann E. P., Franchini G., Manzari V., Wong-Staal F., Gallo R. C. 1984; Molecular cloning of a unique T-cell leukemia virus (HTLV-IIMO). Proceedings of the National Academy of Sciences, U.S.A. 81:993–997
    [Google Scholar]
  7. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de The G. 1985; Antibodies to human T-lympotropic virus type I in a patient with tropical spastic paraparesis. Lancet ii:407–109
    [Google Scholar]
  8. Hall W. W., Kaplan M. H., Salahuddin S. Z., Oyaizu N., Gurgo C., Coronesi M., Nagashima K., Gallo R. C. 1990 Concomitant infections with human T-cell leukemia viruses (HTLVs) and human immunodeficiency virus (HIV) : identification of HTLV-II infection in intravenous drug abusers (IVDAs). In Human Retrovirology: HTLV pp. 125–127 Edited by Blattner W. A. New York: Raven Press;
    [Google Scholar]
  9. Hall W. W., Takahashi H., Liu C, Kaplan M. H., Scheewind O., Ijichi S., Nagashima K., Gallo R. C. 1992; Multiple isolates and characteristics of human T-cell leukemia virus type II. Journal of Virology 66:2456–2463
    [Google Scholar]
  10. Hjelle B. 1991; Human T-cell leukemia/lymphoma viruses: life cycle, pathogenicity, epidemiology and diagnosis. Archives of Pathology and Laboratory Medicine 115:119–122
    [Google Scholar]
  11. Hjelle B., Chaney R. 1992; Variation of functional HTLV-II tax alleles among isolates from an endemic population : lack of evidence for oncogenic determinant in tax. Journal of Medical Virology 36:136–141
    [Google Scholar]
  12. Hjelle B., Scalf R., Swenson S. 1990; High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence specific oligonucleotide hybridization. Blood 76:450–454
    [Google Scholar]
  13. Innis M. A., Myambo K. B., Gelfand D. H., Brown X. Y. Z. 1988; DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction amplified DNA. Proceedings of the National Academy of Sciences, U.S.A. 85:9436–9440
    [Google Scholar]
  14. Kalyanaraman V. S., Sarngadharan M. G., Robert-Guroff M., Miyoshi I., Blayney D., Golde D., Gallo R. C. 1982; A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218:571–573
    [Google Scholar]
  15. Kalyanaraman V. S., Narayanan P., Feorino P., Ramsey R. B., Palmer E. L., Chorba T., McDougal S., Getchell J. P., Holloway B., Harrison A. K., Cabradilla C. D., Telfer M., Evatt B. 1985; Isolation and characterization of human T-cell leukemia virus type II from a hemophilia-A patient with pancytopenia. EMBO Journal 4:1455–1460
    [Google Scholar]
  16. Khabbaz R. F., Hartel D., Lairmore M., Horsburgh C. R., Schoenbaum E. E., Roberts B., Hartley T. M., Friedland G. 1991; Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?. Journal of Infectious Diseases 163:252–256
    [Google Scholar]
  17. Kim J. H., Kaufman P. A., Hanly S. M., Rimsky L. T., Greene W. C. 1991; Rex transregulation of human T-cell leukemia virus type-II gene expression. Journal of Virology 65:405–414
    [Google Scholar]
  18. Klein G., Lindahl T., Jondal M., Leibold W., Menezes J., Nilsson K., Sundstrom X. 1974; Continuous lymphoid cell lines with characteristics of B-cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proceedings of the National Academy of Sciences, U.S.A. 71:3283–3286
    [Google Scholar]
  19. Kwok S., Gallo D., Hanson C., McKinney N., Poiesz B., Sninsky J. J. 1990; High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Research and Human Retroviruses 6:561–565
    [Google Scholar]
  20. Lairmore M. D., Jacobson S., Gracia F., De B. K., Castillo L., Larreategui M., Roberts B. D., Levine P. H., Blattner W. A., Kaplan J. E. 1990; Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proceedings of the National Academy of Sciences, U.S.A. 87:8840–8844
    [Google Scholar]
  21. Lee H. H., Swanson P., Shorty V. S., Zack J. A., Rosenblatt J. D., Chen I. S. Y. 1989; High rate of HTLV-II infection in seropositive IV drug abusers from New Orleans. Science 244:471–475
    [Google Scholar]
  22. Lee H. H., Swanson P., Rosenblatt J. D., Chen I. S. Y., Sherwood W. C., Smith D. E., Tegtmeier G. E., Fernando L. P., Fang C. T., Osame M., Kleinman S. H. 1991; Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet ii:1435–1439
    [Google Scholar]
  23. Ohta M., Nyunoya H., Tanaka H., Okamoto T., Akaji T., Shimotohno K. 1988; Identification of a cis-regulatory element involved in accumulation of human T-cell leukemia virus type II genomic mRNA. Journal of Virology 62:4445–4449
    [Google Scholar]
  24. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. 1986; HTLV-I associated myelopathy, a new clinical entity. Lancet i:1031–1032
    [Google Scholar]
  25. Page J. B., Lai S. H., Chitwood D. D., Klimas N. G., Smith P. C., Fletcher M. A. 1990; HTLV-I/II seropositivity and death for AIDS among HIV-1 seropositive intravenous drug users. Lancet i:1439–1441
    [Google Scholar]
  26. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. 1980; Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences, U.S.A. 77:7415–7419
    [Google Scholar]
  27. Robert-Guroff M., Weiss S. H., Giron J. A., Jenning A. M., Ginzburg H. M., Margolis I. B., Blattner W. A., Gallo R. C. 1986; Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. Journal of the American Medical Association 255:3133–3137
    [Google Scholar]
  28. Rosen A. C., Park R., Sodroski J. G., Haseltine W. A. 1987; Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression. Proceedings of the National Academy of Sciences, U.S.A. 84:4919–4923
    [Google Scholar]
  29. Rosenblatt J. D., Golde D. W., Wachsman W., Jacobs A., Schmidt G., Quan S., Gasson J. C., Chen I. S. Y. 1986; A second HTLV-II isolate associated with atypical hairy-cell leukemia. New England Journal of Medicine 315:372–375
    [Google Scholar]
  30. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, U.S.A. 74:5463–5467
    [Google Scholar]
  31. Shimotohno K., Golde D. W., Miwa M., Sugimura T., Chen I. S. Y. 1984; Nucleotide sequence analysis of the long terminal repeat of human T-cell leukemia virus type II. Proceedings of the National Academy of Sciences, U.S.A. 81:1079–1083
    [Google Scholar]
  32. Shimotohno K., Takahashi Y., Shimizu N., Gojobori T., Golde D. W., Chen I. S. Y., Miwa M., Sugimura T. 1985; Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proceedings of the National Academy of Sciences, U.S.A. 82:3101–3105
    [Google Scholar]
  33. Shimotohno K., Takano M., Teruuchi T., Miwa M. 1986; Requirement of multiple copies of 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-activation of transcription. Proceedings of the National Academy of Sciences, U.S.A. 83:8112–8116
    [Google Scholar]
  34. Sodroski J., Trus M., Perkins D., Patarca R., Wong-Staal F., Gelmann E., Gallo R. C., Haseltine W. A. 1984a; Repetitive structure in the long terminal element of a type II human T-cell leukemia virus. Proceedings of the National Academy of Sciences, U.S.A. 81:4617–4621
    [Google Scholar]
  35. Sodroski J. G., Rosen C. A., Haseltine W. A. 1984b; Transacting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381–385
    [Google Scholar]
  36. Tedder R. S., Shanson D. C., Jeffries R., Chiengsong-Popov R., Dalgleish A., Clapham P., Nagy Y., Weiss R. A. 1984; Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk for AIDS. Lancet ii:125–128
    [Google Scholar]
  37. Varnier O. E., Lillo F., Alexander S. S., Forbis R. M., Present N., Lazzarin A. 1991; HTLV seroreactivity in Italian intravenous drug addicts is primarily due to HTLV-II infection. Journal of the American Medical Association 265:547
    [Google Scholar]
  38. Yoshida M., Miyoshi I., Hinuma Y. 1982; Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proceedings of the National Academy of Sciences, U.S.A. 79:2031–2035
    [Google Scholar]
  39. Zella D., Mori L., Sala M., Ferrante P., Casoli C., Magnani G., Achilli G., Cattaneo E., Lori F., Bertazzoni U. 1990; HTLV-II infection in Italian drug abusers. Lancet ii:575–576
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-74-3-437
Loading
/content/journal/jgv/10.1099/0022-1317-74-3-437
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error